Search

Your search keyword '"Lorelei A. Mucci"' showing total 739 results

Search Constraints

Start Over You searched for: Author "Lorelei A. Mucci" Remove constraint Author: "Lorelei A. Mucci"
739 results on '"Lorelei A. Mucci"'

Search Results

1. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysisResearch in context

2. Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer

3. Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity

4. Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry

5. IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer

6. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations

7. Impact of neighborhood socioeconomic status, income segregation, and greenness on blood biomarkers of inflammation

8. Epigenomic analysis of 5-hydroxymethylcytosine (5hmC) reveals novel DNA methylation markers for lung cancers

9. High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program

10. Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer

11. A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study

12. Mediterranean Diet Score and prostate cancer risk in a Swedish population-based case–control study

13. Post-diagnostic Zinc Supplement Use and Prostate Cancer Survival Among Men With Nonmetastatic Prostate Cancer

15. The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer

16. The Imperative for Population-based Cancer Registration of All Metastatic Cancers

18. Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions

19. Regular, Long-Duration Multivitamin Use and Risk of Overall and Aggressive Prostate Cancer in the Health Professionals Follow-Up Study

20. Post-diagnostic health behaviour scores in relation to fatal prostate cancer

21. The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate Cancer

22. Increased RAD21 Promotes Prostate Cancer Development

23. Influence of neighborhood social and natural environment on prostate tumor histology in a cohort of male health professionals

25. Data from Prospective Study of Avocado Consumption and Cancer Risk in U.S. Men and Women

27. Supplementary Figures S1-S6 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate

28. Figure S5 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate

29. Table S11 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate

30. Data from Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells

31. Perspective on this Article from A Large Prospective Study of SEP15 Genetic Variation, Interaction with Plasma Selenium Levels, and Prostate Cancer Risk and Survival

32. Supplementary Tables S1 - S5, Figures S1 - S5 from A Large Multiethnic Genome-Wide Association Study of Prostate Cancer Identifies Novel Risk Variants and Substantial Ethnic Differences

33. Supplemental Table 1 and 2 from Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells

34. Table S1, S2, S3 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate

35. Data from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate

37. Table S9, S10 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate

38. Supplementary Tables 1-12, Supplementary Figures 1-2 from The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer

39. Supplementary Data from Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years

41. Data from Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years

43. Supplementary Table S1 from Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer

46. Data from Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate Tumors

47. Supplementary Table 1 from A Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome after Radiation Therapy for Localized Prostate Cancer

48. Supplemental Tables 1-4 from Selenium- or Vitamin E–Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT

49. Table S3 from Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer

50. Data from Cholesterol Metabolism and Prostate Cancer Lethality

Catalog

Books, media, physical & digital resources